文献速递冠心病外科

左主干冠状动脉疾病患者接受冠状动脉旁路移植术时使用单侧与双侧胸廓内动脉桥血管的血运重建结局:EXCEL试验的启示

Outcomes following surgical revascularization with single versus bilateral internal thoracic arterial grafts in patients with left main coronary artery disease undergoing coronary artery bypass grafting: insights from the EXCEL trial†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

EXCEL试验随机分配1905例左主干冠状动脉疾病患者接受依维莫司洗脱支架经皮冠状动脉介入治疗或冠状动脉旁路移植术,其中905例接受手术者688例(76.0%)使用单侧胸廓内动脉(SITA),217例(24.0%)使用双侧胸廓内动脉(BITA)。3年随访显示,两组死亡、卒中或心肌梗死复合终点无显著差异(SITA 15.6% vs BITA 11.6%,P=0.17),校正基线差异后复合终点(HR 1.12,95%CI 0.71-1.78,P=0.62)和死亡率(HR 1.36,95%CI 0.60-3.12,P=0.46)亦无显著差异。

要点

  • EXCEL试验中905例冠状动脉旁路移植术患者,76.0%使用SITA,24.0%使用BITA。
  • 未校正3年死亡、卒中或心肌梗死复合终点SITA 15.6% vs BITA 11.6%(P=0.17)。
  • 校正后复合终点HR 1.12(95%CI 0.71-1.78,P=0.62),全因死亡HR 1.36(95%CI 0.60-3.12,P=0.46)。

核心结论

  • 在EXCEL试验中,左主干冠状动脉疾病患者接受SITA或BITA血运重建后3年临床结局无差异。

研究设计与样本

  • EXCEL试验随机分配1905例左主干冠状动脉疾病患者接受依维莫司洗脱支架经皮冠状动脉介入治疗或冠状动脉旁路移植术。
  • 905例接受冠状动脉旁路移植术的患者中,688例(76.0%)接受SITA,217例(24.0%)接受BITA。
  • 采用Kaplan-Meier法估计临床事件率,log-rank检验进行比较,多变量Cox回归校正基线协变量差异。

主要发现

  • BITA组患者较SITA组更年轻(66.1±9.5 vs 64.5±9.3岁,P=0.020),女性比例更低(24.3% vs 14.3%,P=0.002),糖尿病比例更低(28.8% vs 15.2%,P<0.001),外周血管疾病患病率更低(10.2% vs 5.5%,P=0.040)。
  • 未校正3年死亡、卒中或心肌梗死复合终点发生率SITA组15.6% vs BITA组11.6%(P=0.17)。
  • 未校正3年全因死亡率SITA组6.7% vs BITA组3.3%(P=0.070)。
  • 卒中、心肌梗死和缺血驱动血运重建结局在两组间无显著差异。
  • 校正基线差异后,死亡、卒中或心肌梗死复合终点(HR 1.12,95%CI 0.71-1.78,P=0.62)和死亡率(HR 1.36,95%CI 0.60-3.12,P=0.46)在SITA组未显著升高。

关键数值与推荐

  • EXCEL试验随机分配1905例左主干冠状动脉疾病患者,其中905例接受冠状动脉旁路移植术。
  • 冠状动脉旁路移植术患者中SITA 688例(76.0%),BITA 217例(24.0%)。
  • 未校正3年死亡、卒中或心肌梗死复合终点SITA 15.6% vs BITA 11.6%(P=0.17)。
  • 校正后死亡、卒中或心肌梗死复合终点HR 1.12(95%CI 0.71-1.78,P=0.62),全因死亡HR 1.36(95%CI 0.60-3.12,P=0.46)。
  • 3年再住院率SITA 35.8% vs BITA 26.0%(P=0.008),校正后HR 1.27(95%CI 0.93-1.74,P=0.13)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Observational data suggest that the use of a single internal thoracic artery (SITA) may result in inferior outcomes compared with bilateral internal thoracic artery (BITA) use for coronary artery bypass grafting (CABG)-a finding not yet supported by randomized trial outcomes. However, the optimal number of internal thoracic artery grafts in patients with left main coronary artery disease has not been investigated. METHODS: The EXCEL trial randomized 1905 patients with left main coronary artery disease to percutaneous coronary intervention with everolimus-eluting stents versus CABG. Among the 905 patients undergoing CABG, 688 (76.0%) received SITA and 217 (24.0%) received BITA. Differences in clinical event rates were estimated using the Kaplan-Meier method and compared with the log-rank test. Multivariable Cox regression was used to adjust for differences in baseline covariates. RESULTS: Compared to SITA, patients treated with BITA were younger (66.1 ± 9.5 vs 64.5 ± 9.3 years, P = 0.020), were less likely female (24.3% vs 14.3%, P = 0.002) and diabetic (28.8% vs 15.2%, P < 0.001), and had a lower prevalence of peripheral vessel disease (10.2% vs 5.5%, P = 0.040). The unadjusted 3-year composite primary endpoint of death, stroke or myocardial infarction (MI) occurred in 15.6% of SITA vs 11.6% of BITA patients (P = 0.17). The SITA group tended to have a higher 3-year rate of all-cause death compared with the BITA group (6.7% vs 3.3%; P = 0.070). Stroke, MI and ischaemia-driven revascularization outcomes were not significantly different between groups. After adjusting for baseline differences, neither the composite of death, stroke or MI [hazard ratio (HR) 1.12, 95% confidence interval (CI) 0.71-1.78; P = 0.62] nor mortality (HR 1.36, 95% CI 0.60-3.12; P = 0.46) was significantly higher with SITA. The rehospitalization rate after 3 years was higher in the SITA group (35.8% vs 26.0%, P = 0.008), a difference which was no longer present after multivariable adjustment (HR 1.27, 95% CI 0.93-1.74; P = 0.13). Sternal wound dehiscence within 30 days did not occur more often in the BITA group compared to the SITA group (1.8% vs 2.2%, P > 0.99). CONCLUSIONS: In the EXCEL trial, there were no clinical differences at 3 years between SITA or BITA revascularization in patients with left main coronary artery disease.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Thuijs DJFM, Head SJ, Stone GW, et al. Outcomes following surgical revascularization with single versus bilateral internal thoracic arterial grafts in patients with left main coronary artery disease undergoing coronary artery bypass grafting: insights from the EXCEL trial†. Eur J Cardiothorac Surg. 2019. PMID: 30165487. doi:10.1093/ejcts/ezy291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。